Tariffs & Pharma Reshoring: President Trump outlined a phased plan for 100% tariffs on imported generic medicines starting Aug. 2028, rising to 200% in 2029, aiming to force U.S. production—though experts warn it may not reliably bring manufacturing home and could raise prices and disrupt supply. Policy & Compliance for Drug Supply: The FDA launched a pilot to boost U.S. manufacturing of animal drugs by giving priority review when both finished products and active ingredients are made domestically, targeting continuity in supply. Industrial Finance & Growth: Graco reported Q2 results with net sales up 3% and operating earnings up 11%, citing tariff refunds and cost control. M&A in Consumer Manufacturing: Utz Brands agreed to be acquired by Intersnack for about $2.9B, taking the snack maker private. Battery & Legal Pressure: LG Energy accused Bosch and others of infringing battery patents in a Texas filing. Aerospace Production Push: Pratt & Whitney Canada will invest C$275M to modernize its Longueuil engine plant, supported by federal and Quebec funding. Skilled Trades Pipeline: BlackRock, Ford, Google and Carhartt launched the Alliance for America’s Skilled Trades to expand apprenticeships amid labor shortages. India Industrial Expansion: India approved two electronics manufacturing clusters in Tamil Nadu totaling over ₹1,012 crore, and expanded the Bharat 6G Alliance to 90 members. EV/Manufacturing Cash Burn Watch: Tesla reported negative free cash flow in Q2 as it ramped AI, battery capacity, robotaxis and next-gen manufacturing.